11. Appetite and Weight Flashcards

(40 cards)

1
Q

obesity health risks

A
6% UK deaths 
metabolic syndrome/type 2 diabetes 
CV disease
liver disease
cancer
reproductive dysfunction
joint problems 
psychological morbidity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

metabolic syndrome

A

constellation of closely associated CV risk factors:
visceral obesity
dyslipidaemia
hyperglycaemia
hypertension
underlying mechanism = insulin resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

pathophysiology of metabolic syndrome

A

increased free fatty acids (lipolysis of visceral fat, gluconeogenesis, dyslipidaemia)
pro-inflammatory cytokines - TNF alpha, IL-6
insulin resistance
decreased GLUT-4 expression
decreased tyrosine kinase activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

type 2 diabetes risks

A

age
obesity
family history
ethnicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

why is type 2 diabetes prevalence increasing?

A

ageing population
increased obesity prevalence (+diagnosed younger)
better detection /diagnosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

obesity and cardiovascular disease

A
metabolic disease + increased:
blood volume and viscosity 
vascular resistance 
hypertension 
left ventricular hypertrophy 
coronary artery disease 
stroke
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

obesity and respiratory system

A

obstructive sleep apnoea
hypoxia/hypercapnia
pulmonary hypertension - right heart failure
accidents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

obesity and GI/liver

A

non-alcoholic fatty liver
non-alcoholic steatohepatitis - may progress to cirrhosis, portal hypertension, hepatocellular cancer
gallstones
reflux

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

obesity and cancer

A

~10% cancer deaths in non smokers

breast, endometrial, oesophagus, colon, renal, thyroid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

obesity - mechanisms of increased cancer

A

increased insulin
increased free IFG-1
increased oestrogen
adipocytokines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

obesity and reproductive system

A

PCOS - oligonmenorrhoea, hirsutism, sub fertility, insulin resistance
male hypogonadism
adverse pregnancy outcomes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

obesity and joints

A

osteoarthritis

gout

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

aetiology of obesity

A

genetic factors
environmental factors
programming
gut microbiome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

genetic causes of obesity

A

rare - obesity associated syndromes, Prader-Willi, Bardet-Biedl
common - polygenic, susceptibility genes

+ hypothyroidism, Cushing’s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

diet and obesity

A

high fat, high sugar
coca-colanisation of developing world
socio-economic factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

obesity and physical activity

A

20-50% total energy expenditure
obesity prevalence related to proxy measures: car ownership, TV viewing
socioeconomic factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

foetal programming

A

‘programming’: stimuli at critical periods have persistent biological effects

stressors: undernutrition, trace elements
mechanism: epigenetic modification

18
Q

life course model

A

factors operating at every stage of life affect health outcomes later in life
pathway of risk between events and health outcomes
worst outcome: low birth weight, excessive weight gain in infancy, adult obesity

19
Q

gut microbiome

A

integral to host homeostasis - absorption, reabsorption
influenced by diet: high fat high fibre
influence disease risk: obesity, type 2 diabetes

20
Q

regulation of appetite and weight

A

slow acting hormones that regulate weight

rapid acting peptides that regulate meal sizes

21
Q

slow acting hormones

A

regulate body weight
leptin insulin
signal body fat % to hypothalamus - decrease food intake and increase energy expenditure

22
Q

rapid acting peptides

A
regulate meal sizes 
cholecystokinin (CCK) - reduce eating 
ghrelin - increase eating 
PYY - reduce eating 
act via hypothalamus
23
Q

arcuate nucleus in hypothalamus

A
accelerator neurons
neuropeptide Y: increases eating 
agouti-related peptide (ArRP): blocks melanocortin receptor 
brake neutrons: POMC neurone 
melanocortin peptides: decrease eating
24
Q

leptin in mice

A

deficiency - mouse models of obesity

leptin treatment reduces obesity in leptin-deficient mice

25
leptin in humans
starvation single: permissive effect ion puberty/reproduction deficiency/mutation of receptors = rare usually: increased leptin concentration with increased fat, ?leptin resistant, ?decreased leptin CNS transport
26
treatment
lifestyle modification pharmacological surgical public health/social
27
lifestyle modification - diet
500-1000kcal energy deficiency low energy density: decreased saturated fat and sugar, increased fruit and veg decrease portion sizes and snacking structured meals/meal replacement
28
lifestyle modification - physical activity
exercise 7 days a week | regardless of weight loss, exercise increases health
29
VLCD and type 2 diabetes
primary care programme patients with type 2 diabetes initial total diet replacement with formula stepped food reintroduction long term maintenance with structured support 46% induced remission if type 2 diabetes
30
lifestyle modification usual targets and problems
10% weight loss, 1-2lb per week 'yo-yo' dieting - regain weight loss obesogenic environment weight loss: results in increased hunger and decreased satiety
31
pharmacological therapy
orlistat | metformin
32
orlistat mechanism
binds and inhibits lipases in lumen of gut prevents hydrolysis of dietary fat into absorbalblke free fatty acids/glycerol excrete ~1/3 dietary fat
33
orlistat adverse effects
flatulence, oily faecal leakage, diarrhoea reduced absorption of fat soluble vitamins (supplement)
34
metformin
best first line for obese patients with type 2 diabetes (all other oral hypoglycaemic agents and insulin cause weight gain) recommended by NICE for prevention of type 2 diabetes in high risk adults
35
problems with pharmacological treatment
can only increase 3-4 fold proportion of patients who achieve 5% weight loss weight regained after treatment stops
36
surgical treatments
laparoscopic adjustable banding | roux-en-Y gastric bypass
37
laparoscopic adjustable banding
restrictive only | inject/withdraw saline to adjust band diameter
38
roux-en-Y gastric bypass
restrictive malabsorptive alterations in but hormones and bile acid flow contribute to weight loss micronutrient deficiencies - supplemented with iron, B12, folate, calcium, vitamin D dumping syndrome - GI/vasomotor symptoms endocrine factors important in effects increased satiety is key
39
advantages of weight loss surgery
weight loss: 25-30% resolves/improves comorbidities saves costs
40
disadvantages of weight loss surgery
preoperative mortality/morbidity long term follow up some weight regain expense